ASCEND BY NTHRYS
Research Abroad Products

Applied Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 109–120 of 200 project topics
Immune Tolerance Signature Biomarker Kit for Transplant Trial Stratification
A licensed biomarker test measures circulating regulatory T-cell frequencies, B-regulatory cell markers, and tolerance-associated serum proteins to predict transplant acceptance and rejection risk. This diagnostic kit generates high-margin recurring revenue while enabling transplant programs to enroll only patients with optimal immune tolerance profiles, reducing clinical failure rates.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Antigen-Specific B-Cell Response Monitoring Platform for Clinical Trials
A comprehensive testing platform quantifies vaccine-induced or disease-relevant antibody-secreting cell frequencies, avidity, and isotype profiles using proprietary ELISPOT and flow cytometry assay combinations. This specialized monitoring service generates high-volume recurring revenue while providing objective immunogenicity endpoints that strengthen regulatory submissions and reduce trial operational complexity.
Immune Profiling for Clinical Trial Stratification Click to view more details →
High-Throughput TLR Agonist Screening Platform
A cloud-based SaaS platform that enables rapid screening and optimization of Toll-like receptor agonists through automated assays and AI-driven molecular design. This tool accelerates drug discovery timelines by 40-60% and reduces preclinical development costs for immunotherapy developers.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Complement System Inhibitor Discovery Service
A specialized contract research service offering target identification, validation, and lead compound generation for complement cascade modulation therapeutics. The service generates recurring revenue through milestone-based engagement models and positions clients for rapid clinical advancement.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
NLR Inflammasome Activation Profiling Tool
A proprietary diagnostic and screening tool that profiles NOD-like receptor inflammasome activation across diverse cell types and disease contexts using multiplexed biomarkers. This enables pharmaceutical companies to identify and validate novel anti-inflammatory drug candidates with precision mechanism-of-action data.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Pattern Recognition Receptor Ligand Library Database
A commercialized searchable database and virtual screening platform containing 50,000+ catalogued PRR ligands with binding kinetics and immunogenicity profiles. Companies access this through annual subscription licensing to rapidly identify potential innate immune activators for vaccine and immunostimulant development.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Innate Lymphoid Cell Differentiation Screening Kit
A ready-to-use commercial kit system enabling rapid screening of small molecules and biologics that modulate ILC1, ILC2, and ILC3 differentiation and activation. Pharmaceutical and biotech firms use this for early-stage discovery of novel immunomodulatory agents with differentiated mechanisms.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Neutrophil Extracellular Trap Formation Assay Platform
An integrated microfluidic and imaging-based platform that quantifies NET formation kinetics and identifies NET-modulating drug candidates in real-time. The platform supports licensing agreements with pharmaceutical companies developing therapies for auto-inflammatory and cancer immunotherapy indications.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Macrophage Polarization Biomarker Analytics Engine
An AI-powered software platform that predicts and profiles M1/M2 macrophage phenotypes using transcriptomic and proteomic data to guide immunotherapy design. This SaaS offering generates subscription revenue while enabling faster clinical translation of macrophage-targeting therapeutics.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Cytokine Storm Modulation Compound Identification Service
A specialized discovery service combining high-throughput screening with systems biology modeling to identify compounds that selectively dampen pathological cytokine cascades. The service monetizes through success-based fee structures and technology licensing to biopharmaceutical developers.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Interferon Pathway Activation Reporter Cell Lines
A commercial product line offering engineered reporter cell lines with fluorescent and luminescent readouts for type I and III interferon pathway activation. These cells generate recurring revenue through direct sales and support drug screening for antivirals, cancer immunotherapies, and innate immune stimulants.
Innate Immunity Drug Target Discovery Platforms Click to view more details →
Antimicrobial Peptide Efficacy Prediction Software
A machine learning software platform that predicts antimicrobial peptide activity, immunogenicity, and off-target effects to accelerate therapeutic AMP development. The platform is licensed to large pharma and synthetic biology companies as a subscription service, enabling faster go-to-market for peptide-based innate immune modulators.
Innate Immunity Drug Target Discovery Platforms Click to view more details →